2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells

Open Access

Peer-reviewed

Research Article

David Sharon,

Affiliation Department of Oncology, University of Alberta, Edmonton, Alberta, Canada
⨯
Michael Schümann,

Current address: CSL Behring, Marburg, Germany

Affiliation Institut für Virologie, Klinikum der Philipps-Universität Marburg, Marburg, Germany
⨯
Sheena MacLeod,

Affiliation Department of Oncology, University of Alberta, Edmonton, Alberta, Canada
⨯
Robyn McPherson,

Affiliation Department of Oncology, University of Alberta, Edmonton, Alberta, Canada
⨯
Shyambabu Chaurasiya,

Affiliation Department of Oncology, University of Alberta, Edmonton, Alberta, Canada
⨯
Andrew Shaw,

Affiliation Department of Oncology, University of Alberta, Edmonton, Alberta, Canada
⨯
Mary M. Hitt

* E-mail: mary.hitt@albertahealthservices.ca

Affiliation Department of Oncology, University of Alberta, Edmonton, Alberta, Canada
⨯

Reader Comments (0)

Viral replication
Is the Subject Area "Viral replication" applicable to this article?

Thanks for your feedback.
Adenoviruses
Is the Subject Area "Adenoviruses" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
DNA damage
Is the Subject Area "DNA damage" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
DNA replication
Is the Subject Area "DNA replication" applicable to this article?

Thanks for your feedback.
Cell death
Is the Subject Area "Cell death" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.